Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Pharmaceutical Congress of São Paulo. Unidade: FCF
Assuntos: POLIMORFISMO, BIOTRANSFORMAÇÃO
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf. Acesso em: 07 nov. 2024. , 2019APA
Genvigir, F. D. V., Campos-Salazar, A. B., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Hirata, M. H., et al. (2019). CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdfNLM
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Hirata MH, Oliveira G, Herrero MJ, Pellicer SFA, Hirata RDC. CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 39 res. CFSP078.[citado 2024 nov. 07 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdfVancouver
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Hirata MH, Oliveira G, Herrero MJ, Pellicer SFA, Hirata RDC. CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 39 res. CFSP078.[citado 2024 nov. 07 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf